Home › Funds › Chicago Capital Management, LLC › ESPR

Chicago Capital Management, LLC position in ESPR

ESPERION THERAPEUTICS INC NE

Chicago Capital Management, LLC reported holding 830,935 shares of ESPR (ESPERION THERAPEUTICS INC NE) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 2.48% of its reported portfolio and ranking #18 among its reported holdings. Chicago Capital Management, LLC has disclosed ESPR holdings in 3 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)830.93K sh
Reported value held$2.61M
Portfolio Weight2.48%
First reportedQ1 2025
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Chicago Capital Management, LLC's ESPR position evolved

Chicago Capital Management, LLC first disclosed a stake in ESPR in Q1 2025 at 7,500 shares (US$7.5M). Across 3 filings, Chicago Capital Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 830,935 shares valued at US$2.6M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 7.50K $7.49M New
Q2 2025 7.50K $7.42M Hold
Q2 2026 830.93K $2.61M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ESPR and 13F data

ESPR (ESPERION THERAPEUTICS INC NE) is a company whose sector is not yet classified in our data. 41 other funds we track also report a position in ESPR — the largest reported positions include GLAZER CAPITAL, LLC (US$70.8M), ODDO BHF ASSET MANAGEMENT SAS (US$15.8M), Beryl Capital Management LLC (US$14.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ESPR

All ESPR fund holders →

FAQ

How long has Chicago Capital Management, LLC held ESPR?

Chicago Capital Management, LLC has disclosed ESPR holdings in 3 of the last 6 reported quarters, going back to Q1 2025.

What is Chicago Capital Management, LLC's current position in ESPR?

As of Q2 2026, Chicago Capital Management, LLC holds 830.93K shares of ESPR (ESPERION THERAPEUTICS INC NE), valued at $2.61M, representing 2.48% of its reported portfolio and ranking #18.

Has Chicago Capital Management, LLC been buying or selling ESPR?

In the latest 13F filing (Q2 2026), Chicago Capital Management, LLC newly opened its position in ESPR.

Which other funds hold ESPR?

Other major institutional holders of ESPR include GLAZER CAPITAL, LLC, ODDO BHF ASSET MANAGEMENT SAS, Beryl Capital Management LLC, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.